Pear Therapeutics, Inc. filed a motion in the US Bankruptcy Court seeking the extension of its exclusivity periods on July 20, 2023. As per the motion, the debtor seeks to extend its exclusivity periods for both, to file a plan and to solicit votes on a plan, by 90 days i.e. up to November 6, 2023 and January 2, 2024, respectively. The debtor?s current exclusivity period and solicitation period would expire on August 7, 2023 and October 4, 2023, respectively.